Walker & Dunlop Announces Second Quarter 2025 Earnings Conference Call Details
The Company will host a conference call to discuss the quarterly results on August 7, 2025, at 8:30 a.m. Eastern time. Listeners can access the call by dialing (888) 394-8218 from within the United States or (773) 305-6853 from outside the United States and are asked to reference the Confirmation Code: 1660785. A simultaneous webcast of the call will be available via the link below:
https://event.webcasts.com/starthere.jsp?ei=1703886&tp_key=534299e204
A webcast replay will be available on the Investor Relations section of the Company's website at https://investors.walkerdunlop.com/.
About Walker & Dunlop
Walker & Dunlop (NYSE: WD) is one of the largest commercial real estate finance and advisory services firms in the United States and internationally. Our ideas and capital create communities where people live, work, shop, and play. Our innovative people, breadth of our brand, and our technological capabilities make us one of the most insightful and client-focused firms in the commercial real estate industry.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
an hour ago
- CTV News
Keurig Dr Pepper quarterly revenue beats expectations fueled by U.S. demand
The logo for Keurig Dr. Pepper appears above a trading post on the floor of the New York Stock Exchange, Thursday, July 12, 2018. (AP Photo/Richard Drew, File) Keurig Dr Pepper reported second-quarter slightly revenue above Wall Street expectations on Thursday, driven by strong demand for its energy drinks and soft beverages, especially in the U.S. Why it is important The Snapple maker enjoyed resilient demand for its higher-priced ready-to-drink beverages, including Yoo-Hoo and Crush, and through the popularity of its majority-owned energy-drink maker, Ghost. The company's results mirror those of bigger rivals PepsiCo's and Coca-Cola's, both of which recently beat quarterly estimates on strong demand. Key quote 'Though the back half will present new challenges, we are on track to deliver our 2025 outlook,' said CEO Tim Cofer. Market reaction Shares of Keurig Dr Pepper, which rose about four per cent so far this year, were flat in premarket trading. Context Instability arising from U.S. President Donald Trump's fluctuating tariff policies and the resulting trade tensions has led to a decline in consumer spending. Keurig also faces a direct risk from tariffs on its business in Canada and Mexico, especially due to the Canadian boycott of U.S. products, and the impact of tariff-driven coffee prices. By the numbers Net sales for the quarter rose 6.1 per cent to US$4.16 billion, compared with estimates of US$4.14 billion, according to data compiled by LSEG. Keurig Dr Pepper posted an adjusted profit of 49 cents per share, in line with analysts' estimates. The Sun Drop maker's volumes grew five per cent compared to a 1.8 per cent rise a year ago, with Ghost contributing 4 percentage points to the volume growth. Net sales in the U.S. beverages segment rose 10.5 per cent compared to a 3.3 per cent rise in the year-ago quarter. The company continues to expect annual net sales to grow in the mid-single-digit range and adjusted profit to grow in the high-single digits. --- Reporting by Neil J Kanatt in Bengaluru; Editing by Shailesh Kuber
Globe and Mail
an hour ago
- Globe and Mail
IBM Surpasses Q2 Earnings Estimates on Solid Demand Trends
International Business Machines Corporation IBM reported strong second-quarter 2025 results, with adjusted earnings and revenues beating the respective Zacks Consensus Estimate. The company witnessed healthy demand trends for hybrid cloud and artificial intelligence (AI) solutions with a client-focused portfolio and broad-based growth. IBM exceeded the target metrics related to revenue, profitability and cash flow growth for the quarter. Despite economic uncertainty stemming from geopolitical issues, supply chain vulnerabilities, constrained federal spending and the evolving landscape of interest rates and inflation levels, the company expects to deliver sustainable growth through advanced technology and deep consulting expertise. Net Income On a GAAP basis, net income for the reported quarter was $2.19 billion or $2.31 per share compared with $1.83 billion or $1.96 per share in the year-ago quarter. The significant improvement in GAAP earnings was primarily led by top-line growth. Excluding non-recurring items, non-GAAP net income from continuing operations was $2.80 per share compared with $2.43 in the prior-year quarter. The bottom line beat the Zacks Consensus Estimate by 16 cents. Quarter Details Quarterly total revenues increased to $16.98 billion from $15.77 billion on strong demand for hybrid cloud and AI, driving growth in the Software segment. On a constant currency basis, revenues were up 5% year over year. The top line exceeded the consensus estimate of $16.58 billion. Gross profit improved to $9.98 billion from $8.95 billion in the prior-year quarter, resulting in respective gross margins of 58.8% and 56.8% owing to a strong portfolio mix. Total expenses increased to $7.38 billion from $6.73 billion due to higher selling, general and administrative expenses and research and development costs. Segmental Performance Software: Revenues improved to $7.39 billion from $6.74 billion, driven by growth in Hybrid Cloud (Red Hat, up 16%), Automation (16%), Data (9%) and Transaction Processing (1%). The segment's revenues missed our estimate of $7.52 billion despite solid hybrid cloud traction. Segment profit was $2.3 billion compared with $2.1 billion in the year-ago quarter for margins of 31.1% and 31.3%, respectively. The company is witnessing healthy hybrid cloud adoption by clients and solid demand trends across automation and generative AI offerings like watsonx. Consulting: Revenues were $5.31 billion compared with $5.18 billion a year ago as clients prioritized spending and pulled back on discretionary projects. The segment's revenues beat our estimate of $5.17 billion. Segment profit improved to $562 million from $463 million for margins of 10.6% and 8.9%, respectively. Infrastructure: Revenues were $4.14 billion compared with $3.64 billion on higher demand for hybrid and distributed infrastructure. Segment profit was $965 million compared with $654 million in the year-ago quarter, for respective margins of 23.3% and 17.9%. This reflected strength in the z17 program as AI use cases resonated strongly with clients. Higher investments in the business across areas like AI, hybrid cloud and quantum also buoyed segment performance. Financing: Revenues declined to $166 million from $169 million a year ago. Segment profit was up to $179 million from $77 million in the year-ago quarter for respective margins of 107.9% and 45.3%. Cash Flow & Liquidity During the quarter, IBM generated $1.7 billion in cash from operations compared with $2.07 billion in the year-ago quarter, bringing the respective tallies for the first six months of 2025 and 2024 to $6.07 billion and $6.23 billion. Free cash flow was $2.84 billion in the quarter, up from $2.61 billion in the prior-year period, driven by higher profit and working capital efficiencies. As of June 30, 2025, the company had $11.94 billion in cash and cash equivalents with $55.22 billion of long-term debt. Outlook For 2025, the company expects revenues to grow at least 5% on a constant currency basis, driven by a strong portfolio mix, operating leverage and yield from productivity initiatives. Free cash flow is expected to be in the vicinity of $13.5 billion. Zacks Rank IBM currently carries a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Upcoming Releases Arista Networks Inc. ANET is scheduled to release second-quarter 2025 earnings on Aug. 5. The Zacks Consensus Estimate for earnings is pegged at 65 cents per share, suggesting a growth of 25% from the year-ago reported figure. Arista has a long-term earnings growth expectation of 14.8%. Arista delivered an average earnings surprise of 11.8% in the last four reported quarters. Akamai Technologies, Inc. AKAM is slated to release second-quarter 2025 earnings on Aug. 7. The Zacks Consensus Estimate for earnings is pegged at $1.55 per share, indicating a 1.9% decline from the year-ago reported figure. Akamai has a long-term earnings growth expectation of 8%. Akamai delivered an average earnings surprise of 4.8% in the last four reported quarters. Pinterest, Inc. PINS is set to release second-quarter 2025 earnings on Aug. 7. The Zacks Consensus Estimate for earnings is pegged at 34 cents per share, implying a growth of 17.2% from the year-ago reported figure. Pinterest has a long-term earnings growth expectation of 33.3%. Pinterest delivered an average earnings surprise of 0.5% in the last four reported quarters. 7 Best Stocks for the Next 30 Days Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops." Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Akamai Technologies, Inc. (AKAM): Free Stock Analysis Report Arista Networks, Inc. (ANET): Free Stock Analysis Report Pinterest, Inc. (PINS): Free Stock Analysis Report
CTV News
an hour ago
- CTV News
UnitedHealth says it is under a U.S. federal investigation and co-operating
The logo for UnitedHealth Group appears above a trading post on the floor of the New York Stock Exchange, April 17, 2025. (AP Photo/Richard Drew) Shares of UnitedHealth Group slipped Thursday after the health care giant said it was under a U.S. Department of Justice investigation. The company said it has started complying with both criminal and civil requests from federal investigators and it was cooperating with them. '(UnitedHealth) has a long record of responsible conduct and effective compliance,' the company said in a Securities and Exchange Commission filing. Earlier this year, The Wall Street Journal said federal officials had launched a civil fraud investigation into how the company records diagnoses that lead to extra payments for its Medicare Advantage, or MA, plans. Those are privately run versions of the government's Medicare coverage program mostly for people ages 65 and over. The company's UnitedHealthcare business covers more than 8 million people as the nation's largest provider of Medicare Advantage plans. The business has been under pressure in recent quarters due to rising care use and rate cuts. The Journal said in February, citing anonymous sources, that the probe focused on billing practices in recent months. The paper then said earlier this month that a federal criminal health care-fraud unit was investigating how the company used doctors and nurses to gather diagnoses that bolster payments. UnitedHealth Group Inc. said that it reached out to the Justice Department 'after reviewing media reports about investigations into certain aspects of the company's participation in the Medicare program.' UnitedHealth runs one of the nation's largest health insurance and pharmacy benefits management businesses. It also operates a growing Optum business that provides care and technology support. UnitedHealth raked in more than US$400 billion in revenue last year as the third-largest company in the Fortune 500. Last year, its share price topped $630 to reach a new all-time high. But company shares have mostly shed value since December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan on his way to the company's annual investor meeting. A 26-year-old suspect, Luigi Mangione, has been charged in connection with the shooting. In April, shares plunged after the company cut its forecast due to a spike in health care use. A month later, former CEO Andrew Witty resigned and the company withdrew its forecast. The stock price slipped another 2%, or $5.12, to $287.39 Thursday morning. That represents a 54% drop from its all-time high. UnitedHealth will report its second-quarter results next Tuesday. Tom Murphy, The Associated Press
